Market Cap | ₹229Cr |
ROE | 6.80% |
P/E Ratio(TTM) | 62.90 |
EPS(TTM) | 2.21 |
P/B Ratio | 4.28 |
Dividend Yield | 0.00% |
Industry P/E | 85.40 |
Book Value | 32.44 |
Debt to Equity | 0.00 |
Face Value | 10 |
Parent Organisation | Nephro Care India |
NSE Symbol | NEPHROCARE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Max Healthcare Institute | NA (0.00%) | 96.94 | ||
Apollo Hospitals Enterprise | NA (0.00%) | 67.59 | ||
Fortis Healthcare | NA (0.00%) | 88.35 | ||
Global Health | NA (0.00%) | 69.74 |